Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
KODAMA CHEMICAL, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 18 times, Exceeds Full-Year Plan
4222 KODAMA CHEMICAL INDUSTRY CO.,LTD. 【J-GAAP】
Earnings ReportKODAMA CHEMICAL INDUSTRY CO.,LTD. <4222> [TSE Std] announced its financial results after the market closed on February 13th (16:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) surged 18 times that of the same period last year, reaching 1835 million yen. Progress toward the full-year plan of 850 million yen is 215.9%, already exceeding the target and also exceeding the five-year average of 64.7%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary loss for the January to March period (4Q) is expected to expand to a loss of 985 million yen (compared to a loss of 6 million yen in the same period last year). However, if the fourth-quarter performance remains at the same level as the first three quarters, the full-year plan may be increased.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit surged 11 times that of the same period last year, reaching 1201 million yen. The operating profit margin improved from 3.0% in the same period last year to 3.9%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 11,112 | 118 | 8 | -177 | -26.7 | 33.3 | Feb 9, 2024 | J-GAAP |
| Apr - Dec, 2024 | 11,764 | 153 | 103 | -75 | -13.6 | 106.2 | Feb 12, 2025 | J-GAAP |
| Apr - Dec, 2025 | 61,673 | 1,693 | 1,835 | 23,803 | 1,524.0 | 215.9 | Feb 13, 2026 | J-GAAP |
| YoY | +424.3% | +1,006.5% | +1,681.6% | - | - |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 8,062 | 128 | 102 | -4 | -0.5 | 0 | May 14, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 39,514 | 539 | 216 | -2,805 | -180.5 | 0 | Nov 13, 2025 | J-GAAP |
| YoY | +390.1% | +321.1% | +111.8% | -70,025.0% | -37,508.3% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 14,696 | 165 | 24 | -243 | -36.4 | 0 | May 15, 2024 | J-GAAP |
| Mar, 2025 | 15,842 | 162 | 97 | -132 | -15.8 | 0 | May 14, 2025 | J-GAAP |
| Mar, 2026 Guidance | 80,000 | 1,400 | 850 | 20,000 | 1,287.1 | 0 | Nov 13, 2025 | J-GAAP |
| YoY | +405.0% | +764.2% | +776.3% | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 3,984 | 119 | 108 | 53 | 9.6 | 3.0 | Feb 12, 2025 | J-GAAP |
| Jan - Mar, 2025 | 4,078 | 9 | -6 | -57 | -6.8 | 0.2 | May 14, 2025 | J-GAAP |
| Apr - Jun, 2025 | 20,087 | 427 | 7 | 22,384 | 1,433.3 | 2.1 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 20,399 | 434 | 627 | 421 | 27.0 | 2.1 | Nov 13, 2025 | J-GAAP |
| Oct - Dec, 2025 | 21,187 | 832 | 1,201 | 998 | 63.9 | 3.9 | Feb 13, 2026 | J-GAAP |
| YoY | +431.8% | +599.2% | +1,012.0% | +1,783.0% | +565.6% |
Related Articles
CRG HOLDINGS, Oct-Dec (1Q) Ordinary Profit Increases by 16%, Current Fiscal Year Dividend Revised from no dividend to Undecided
UNBANKED, Apr-Dec (Cumulative 3Q) Net Income Turns to Loss, Oct-Dec Net Income Turns to Loss
TAKE&GIVE NEEDS, Ordinary Profit for The Current Fiscal Year, with a Change in the Fiscal Year-End, is 0.72 Billion Yen
S Science, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens
Fixstars, Oct-Dec (1Q) Ordinary Profit Decreases by 10%
Dualtap, First Half Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Turns to Profit
Movin Strategic, 30% Increase in Ordinary Profit, Update Record High for Sixth Consecutive Term
SENKO, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 3%
PRISM BioLab, Oct-Dec (1Q) Ordinary Profit Loss Widens
Wagokoro, 39% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, First Dividend Since Listing at 12 Yen This Fiscal Year